Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

John Rumsfeld to United States Food and Drug Administration

This is a "connection" page, showing publications John Rumsfeld has written about United States Food and Drug Administration.

 
Connection Strength
 
 
 
0.211
 
  1. Tsai TT, Box TL, Gethoffer H, Noonan G, Varosy PD, Maddox TM, Fihn SD, Gross TP, Jesse RL, Rumsfeld JS. Feasibility of proactive medical device surveillance: the VA Clinical Assessment Reporting and Tracking (CART) program. Med Care. 2013 Mar; 51(3 Suppl 1):S57-61.
    View in: PubMed
    Score: 0.100
  2. Rumsfeld JS, Peterson ED. Achieving meaningful device surveillance: from reaction to proaction. JAMA. 2010 Nov 10; 304(18):2065-6.
    View in: PubMed
    Score: 0.085
  3. Carroll JD, Edwards FH, Marinac-Dabic D, Brindis RG, Grover FL, Peterson ED, Tuzcu EM, Shahian DM, Rumsfeld JS, Shewan CM, Hewitt K, Holmes DR, Mack MJ. The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. J Am Coll Cardiol. 2013 Sep 10; 62(11):1026-34.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)